
Conference Coverage
1 day ago
ICYMI: Highlights From ASCO GU 20254 days ago
ICYMI: Highlights From SABCS 20254 days ago
ICYMI: Highlights From COA 20255 days ago
ICYMI: Highlights From ASH 202511 days ago
ICYMI: Highlights From ASCO 202514 days ago
ICYMI: Highlights From AMCP 2025Latest Content

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

DeFi trial results show that continuous nirogacestat provides durable tumor control, ongoing shrinkage, sustained symptom improvement, and a stable safety profile over several years.

Discover the latest breakthroughs in multiple sclerosis treatments and research developments shaping the future of MS care in 2025.

Top articles in non–small cell lung cancer (NSCLC) include FDA approvals, improved outcomes due to certain treatments, and updated data presented at conferences.

AI revolutionizes pharmacy by automating workloads, enhancing patient care, and navigating drug pricing challenges amid evolving federal policies.

These pieces highlight several newly approved therapies that expanded treatment options across multiple disease states.

From home-based monitoring and subcutaneous immunotherapy to expanded community cancer networks, 2025 marked a pivotal year in rethinking how cancer care is delivered.

New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year.

New research highlights the effectiveness of RSV preF vaccines in preventing severe respiratory infections in older adults.

Highlights from the 2025 Muscular Dystrophy Association (MDA) Conference include clinical updates, expert insights, and breaking trial findings.

Scott Soefje, PharmD, outlines proactive financial screening, flexible payment models, and stronger academic-community partnerships for advanced cancer care.

























































